The worldwide biotechnology industry was worth USD 752.88 billion in 2020, and it is predicted to increase at a 15.83 percent compound annual growth rate (CAGR) from 2021 to 2028. Because of the rise of the biotechnology sector in developing nations like India and China, the market is being driven by favourable government initiatives. Government activities are aimed at streamlining the medication regulatory pathway, standardising clinical studies, enhancing reimbursement policies, and expediting the product approval process, all of which will provide the industry with lucrative growth potential. The development of therapeutic proteins and other medications has been aided by the growing use of biotech solutions. The need for medication discovery and development has grown as the prevalence of chronic diseases has increased. Due to the broad nature of the application, it is being employed more frequently in various industrial areas. The increasing use of organic products in agriculture is also contributing to market expansion.